DIC India per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Dec 2025FY25Dec 2024FY24Dec 2023FY23Dec 2022FY22 and earlierAlpha Plus
₹31.52₹18.93₹21.29−₹24.70₹44.65
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹31.52₹18.93₹21.29−₹24.70₹44.65
₹466.99₹466.99₹452.46₹431.77₹460.01
₹1,067.19₹971.55₹960.53₹902.99₹949.98
—₹46.61₹17.85₹5.73₹44.07
₹34.24₹34.24₹8.83−₹30.57−₹31.65
—₹3.98₹0.04₹2.02₹5.00
0.90.90.90.90.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

DICIND₹528.00

DIC India Limited

· Chemicals
₹ CroreMcap ₹485 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/12/2022
FY24
31/12/2023
FY25
31/12/2024
FY26
31/12/2025
Current/LTM
TTM · last close
Basic EPS44.65-24.7021.2918.9331.52
Diluted EPS44.65-24.7021.2918.9331.52
Book Value per Share460.01431.77452.46466.99466.99
Revenue per Share949.98902.99960.53971.551,067.19
Cash Flow per Share44.075.7317.8546.61—
Free Cash Flow per Share-31.65-30.578.8334.2434.24
Dividends per Share5.002.020.043.98—
Shares Outstanding (cr)0.90.90.90.90.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.